Date:6/13/2010

re events or results. Any or all of the Company's forward-looking statements may turn out to be wrong. They can be affected by inaccurate assumptions, risks and uncertainties and other factors which could cause actual events or results to be materially different from those expressed or implied in the forward-looking statements. In evaluating these statements, readers should consider various factors, including the risks described in "Item 1A. Risk Factors" and elsewhere in the Company's 2010 Annual Report on Form 10-K. These factors may cause the Company's actual results to differ materially from any forward-looking statement. In addition, new factors emerge from time to time and it is not possible for the Company to predict all factors that may cause actual results to differ materially from those contained in any forward-looking statements. The Company disclaims any obligation to publicly update any forward-looking statements to reflect events or circumstances after the date of this document, except as required by applicable law.

Use of Non-GAAP Financial Measures

GAAP results for the fourth quarters and fiscal years ended March 31, 2010 and 2009, include non-cash losses or gains related to change in fair value of the Company's convertible notes. To supplement the Company's condensed consolidated financial statements presented on a GAAP basis, the Company has provided non-GAAP financial information excluding the impact of these items in this release, which are non-GAAP net income and non-GAAP diluted earnings per share. The Company's management believes that these non-GAAP measures provide investors with a better understanding of how the results relate to the Company's historical performance. A reconciliation of adjustments to GAAP results appears in the tables accompanying this press release. This additional non-GAAP information is not meant to be considered in
'/>"/>

SOURCE China-Biotics, Inc. Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Related biology technology :

1. China-Biotics, Inc. Appointed Grayling as Strategic Investor Relations Advisor
2. China-Biotics, Inc. Inaugurated the Commercial Production of its New Production Facility
3. China-Biotics, Inc. Reports Third Quarter Fiscal 2010 Financial Results
4. China-Biotics, Inc. Announces Conference Call to Discuss Second Quarter Fiscal 2010 Financial Results
5. China-Biotics, Inc. Appoints New Vice President
6. China-Biotics, Inc. to Attend the SIG 3rd Annual Beijing Management Summit
7. China-Biotics, Inc. Reports First Quarter Fiscal 2010 Financial Results
8. China-Biotics, Inc. Receives High-Technology Enterprise Certification to Qualify for Preferential Income Tax Rate
9. China-Biotics, Inc. Applies for Four Patents on Probiotic Formulations
10. China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results
11. China-Biotics, Inc. Announces Conference Call to Discuss Fourth Quarter and Full Year 2009 Financial Results